SarCaBon: Saracatinib versus placebo for cancer-induced bone pain

• Research type

  Research Study

• Full title

  SarCaBon: A randomised phase II trial of Saracatinib versus placebo for cancer-induced bone pain

• IRAS ID

  128276

• Contact name

  David Andrew

• Contact email

  D.Andrew@sheffield.ac.uk

• Sponsor organisation

  Sheffield Teaching Hospitals NHS Foundation Trust

• Eudract number

  2013-002505-62

• Research summary

  To assess whether Saracatinib is a helpful analgesic compared to placebo in controlling bone pain from cancer using self-reported pain scores from cancer patients.

• REC name

  Yorkshire & The Humber - Sheffield Research Ethics Committee

• REC reference

  13/YH/0263

• Date of REC Opinion

  24 Oct 2013

• REC opinion

  Further Information Favourable Opinion